Le Lézard
Classified in: Health
Subjects: AWD, SVY

Vote for John Brooks Recovery Center for Best of the Press Readers' Choice Awards


MAYS LANDING, N.J., Sept. 22, 2020 /PRNewswire-PRWeb/ -- John Brooks Recovery Center has been nominated for Best Drug/Alcohol Recovery Program in Press of Atlantic City's 2020 Best of the Press Readers' Choice Awards. Voting ends on September 23 and winners will be announced on October 30. Support John Brooks Recovery Center and vote by texting 984 to 609-293-4900 or click here. Voters are encouraged to come back daily to vote.

"We are honored to have been nominated for the Press of Atlantic City's 2020 Best of the Press Readers' Choice Awards," said Michael Santillo, CEO of JBRC. "This is an exciting time in the life of John Brooks Recovery Center as we recently unveiled our new state-of-the-art Residential Treatment Facility located at 1455 Pinewood Boulevard in Mays Landing."

The new $15M facility features 48 short-term beds, 48 long-term beds and 24 detox beds. "Our journey started in 1969 when John Brooks, an Atlantic City resident, former heroin addict and ex-con came to the realization that if he stopped using heroin, he'd stop going to prison," said Santillo. "Shortly thereafter, he was inspired to start a small storefront outpatient program dedicated to helping individuals with substance use disorders."

Originally called Narco, Inc., which later became the Institute for Human Development and eventually John Brooks Recovery Center, the nonprofit has since grown exponentially. "We now provide outpatient, intensive outpatient and opioid treatment with all three approved medications for the treatment of opioid use disorder, 120 long-term residential beds, a jail program providing medication-assisted treatment counseling and we have expanded that program to include recovery support services and care coordination both in the jail and when people leave the jail," Santillo said. "We also have two recovery community centers providing a full array of recovery support services, a recovery housing program and a primary care clinic, in total serving as many as 1,200 individuals."

JBRC's new residential treatment facility will expand its current continuum of care allowing the organization to serve even more people. "This facility will allow us to provide the highest quality, evidence-based treatment in state-of-the-art facilities through a recovery-oriented care model, integrating primary care, behavioral health and recovery support services," Santillo said.

The mission of John Brooks Recovery center is to provide quality, individualized treatment to help individuals overcome substance use disorders. To learn more about John Brooks Recovery Center, call 609-345-2020.

About John Brooks Recovery Center
Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication Assisted Recovery and Inmate Re-entry. To learn more, visit jbrcnj.org or call 609-345-2020.

https://jbrcnj.org/about-us/blog-newsroom/entry/2020/09/18/vote-for-john-brooks-recovery-center.html

Find John Brooks Recovery Center on Facebook
Find John Brooks Recovery Center on Instagram

 

SOURCE John Brooks Recovery Center


These press releases may also interest you

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...

at 10:00
NastLaw LLC announces: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019, your rights may be affected by proposed class action settlements.A...

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...

at 09:38
The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer's atopic dermatitis interactive guide for varying skin tones....



News published on and distributed by: